1-4 of 4
Keywords: Genotype 1
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin

Available to Purchase
Subject Area:
Further Areas
Nghia H. Nguyen, Shelley A. McCormack, Philip Vutien, Brittany E. Yee, Pardha Devaki, David Jencks, Mindie H. Nguyen
Journal: Intervirology
Intervirology (2015) 58 (1): 27–34.
https://doi.org/10.1159/000369097
Published Online: 10 January 2015
..., instructions or products referred to in the content or advertisements. Hepatitis C virus Sustained virologic response Genotype 6 Genotype 1 National Institutes of Health (NIH) 10.13039/100000002 Chronic infection with hepatitis C virus (HCV) is a major global health problem...
View article titled, Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
Open the PDF for Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin in another window
Journal Articles

Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable IL28B Allele-Prevalent Area

Available to Purchase
Subject Area:
Further Areas
Hyun Jung Chung, Jin-Woo Lee, Young Soo Kim, Jung Il Lee
Journal: Intervirology
Intervirology (2013) 56 (3): 178–183.
https://doi.org/10.1159/000345539
Published Online: 09 January 2013
...Hyun Jung Chung; Jin-Woo Lee; Young Soo Kim; Jung Il Lee Objectives: The aim of this study was to evaluate rapid virologic response (RVR) rate after peginterferon (PegIFN) and ribavirin (RBV) dual combination therapy in Korean hepatitis C virus (HCV) genotype 1 patients whose IL28B polymorphism...
View article titled, Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable IL28B Allele-Prevalent Area
Open the PDF for Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable IL28B Allele-Prevalent Area in another window
Journal Articles

Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks

Available to Purchase
Subject Area:
Further Areas
Taisuke Ueda, Hobyung Chung, Masatoshi Kudo, Emi Ishikawa, Sousuke Hayaishi, Chie Tatsumi, Tatsuo Inoue, Norihisa Yada, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima
Journal: Intervirology
Intervirology (2010) 53 (1): 55–59.
https://doi.org/10.1159/000252785
Published Online: 05 January 2010
...) genotype 1 and high viral load. However, the effectiveness of extended treatment in patients whose serum HCV RNA become undetectable later than 24 weeks of treatment (ultra-late virological responder; ULVR) has not yet been determined. Methods: A total of 130 patients infected with HCV genotype 1 and who...
View article titled, Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks
Open the PDF for Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks in another window
Journal Articles

A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load

Available to Purchase
Subject Area:
Further Areas
Namiki Izumi, Yasuhiro Asahina, Masayuki Kurosaki, Masakatsu Uchihara, Yuki Nishimura, Kazunari Inoue, Ken Ueda, Kaoru Tsuchiya, Kousei Hamano, Jun Itakura, Shozo Miyake
Journal: Intervirology
Intervirology (2004) 47 (2): 102–107.
https://doi.org/10.1159/000077833
Published Online: 11 June 2004
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chronic hepatitis C HCV dynamics PEG interferon Ribavirin Genotype 1 Original Paper Intervirology 2004;47:102 107 DOI: 10.1159/000077833...
View article titled, A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load
Open the PDF for A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load in another window